Discovery Laboratories (DSCO) Announces Completion of $14.25 Million Public Offering
5/15/2013 9:32:06 AM
More...
|
Discovery Laboratories (DSCO) Prices $14.25 Million Public Offering of Common Stock
5/13/2013 9:05:55 AM
More...
|
Discovery Laboratories (DSCO) Announces Proposed Public Offering of Common Stock
5/10/2013 9:26:32 AM
More...
|
Discovery Laboratories (DSCO) Reports First Quarter 2013 Financial Results
5/7/2013 6:59:34 AM
More...
|
Discovery Laboratories (DSCO) Announces Recent AFECTAIR® Publications
5/1/2013 10:24:56 AM
More...
|
Discovery Laboratories (DSCO) Receives FDA Recommendations and Request for Clarification Regarding Recently-Submitted SURFAXIN® (lucinactant) Updated Product Specifications
4/15/2013 9:54:05 AM
More...
|
Discovery Laboratories (DSCO) Announces Newly-Released SURFAXIN® (lucinactant) Publications
3/29/2013 9:47:03 AM
More...
|
Discovery Laboratories (DSCO) Reports Fourth Quarter 2012 Financial Results
3/13/2013 7:12:25 AM
More...
|
Discovery Laboratories (DSCO) to Report Fourth Quarter 2012 Results and Hold Conference Call on Wednesday, March 13, 2013
3/7/2013 6:39:27 AM
More...
|
Deerfield Announces $30 Million Investment in Discovery Laboratories (DSCO)
2/14/2013 7:08:06 AM
More...
|
|